The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

and Donald Trump has picked Ozempic-skeptic Robert F. Kennedy Jr. to head the health department. In January, Hims & Hers donated $1 million to Trump's inauguration fund. In the short term, this is ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

In this Saturday edition of BI Today, we're talking about the end of a GLP-1 shortage, and Hollywood's awards season.

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Spencer Durham can be reached at 765-454-8598, by email at spencer.durham@kokomotribune.com or on Twitter at @Durham_KT.

If you’re interested in using Ozempic for weight loss, which is an off-label use, talk with your doctor first. They’ll help determine whether Ozempic is an appropriate weight loss strategy for ...